Maria Weimer
Neurology with Special Qualifications in Child Neurology · New Orleans, LANPI 1659394518
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 239 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 37 manufacturers, the largest accounting for just 14.8% — the pattern of someone who eats at a lot of different presentations.
Across 239 payments — averaging $24.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$855
- Eisai Inc.$435
- SK Life Science, Inc.$411
- Neurelis, Inc.$394
- Jazz Pharmaceuticals Inc.$391
- Supernus Pharmaceuticals, Inc.$367
- plus $3K from 31 others
What the payments were for
- Food & beverage$5,772100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 29 | $855 |
| Eisai Inc. | 21 | $435 |
| SK Life Science, Inc. | 12 | $411 |
| Neurelis, Inc. | 11 | $394 |
| Jazz Pharmaceuticals Inc. | 14 | $391 |
| Supernus Pharmaceuticals, Inc. | 30 | $367 |
| PTC Therapeutics, Inc. | 16 | $343 |
| Sarepta Therapeutics, Inc. | 14 | $300 |
| Biogen | 13 | $280 |
| Sunovion Pharmaceuticals Inc. | 15 | $204 |
| Biomarin Pharmaceutical Inc. | 6 | $189 |
| Genentech, Inc. | 2 | $155 |
| Immedica Pharma US, Inc. | 5 | $117 |
| Argenx US, Inc. | 1 | $115 |
| Genentech USA, Inc. | 5 | $104 |
| Sanofi | 4 | $95 |
| Catalyst Pharmaceuticals, Inc. | 3 | $93 |
| NS Pharma, Inc. | 5 | $93 |
| Greenwich Biosciences, Inc. | 4 | $89 |
| Novartis | 5 | $86 |
| Upsher-smith Laboratories LLC | 3 | $82 |
| Novartis Gene Therapies, Inc. (fka Avexis, Inc.) | 2 | $73 |
| Zevra Therapeutics Inc | 1 | $72 |
| ITF Therapeutics LLC | 2 | $57 |
| Biocodex, Inc. | 1 | $55 |
| Aucta Pharmaceuticals, Inc. | 2 | $49 |
| Zogenix Inc. | 2 | $46 |
| AstraZeneca(2 entities) | 2 | $36 |
| CSL Behring | 1 | $33 |
| Mallinckrodt Enterprises LLC | 1 | $28 |
| Acadia Pharmaceuticals Inc | 1 | $23 |
| AbbVie | 1 | $20 |
| Mirum Pharmaceuticals, Inc. | 1 | $19 |
| Strongbridge US Inc. | 1 | $19 |
| Metacel Pharmaceuticals LLC | 1 | $17 |
| Amneal Pharmaceuticals LLC | 1 | $14 |
| EMD Serono, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,772 in reported general payments places this provider in the 55th percentile of 30 neurology with special qualifications in child neurology providers in Louisiana.
See all neurology with special qualifications in child neurology providers in Louisiana →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxtellar XrOxcarbazepine | 14 | $32,785 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Supernus Pharmaceuticals, Inc.Oxtellar Xr | $367 | $32,78514 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 30 neurology with special qualifications in child neurology providers in Louisiana.
Other neurology with special qualifications in child neurology in New Orleans
- Ann Henderson TiltonNew Orleans$119K
- Joaquin WongNew Orleans$28K
- Allison ConraveyNew Orleans$15K
- David HoughtonNew Orleans$9K
- Jeremy TolerNew Orleans$9K
- Jessica GautreauxNew Orleans$9K
- Daniella MillerNew Orleans$8K
- Rashmi RaoNew Orleans$5K
- Kelly AngelleNew Orleans$3K
- Kayla PenceNew Orleans$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.